GD-TEMSIROLIMUS
GD-TEMSIROLIMUS
Discontinued
DIN Number
02441810
Drug Class
Human
Market Date
N/A
Company
HC
genmed a division of pfizer canada ulc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02441810
AIG Number0152415001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L01EG01 TEMSIROLIMUS
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification10:00.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
TEMSIROLIMUSActive
Strength: 25 MG / ML
Monograph: TEMSIROLIMUS